TY - JOUR
T1 - Protection against radiation-induced mutagenesis at the hprt locus by spermine and N, N-(dithiodi-2, 1-ethanediyl)bis-1, 3-propanediamine (WR-33278)
AU - Shigematsu, N.
AU - Schwartz, J. L.
AU - Grdina, D. J.
N1 - Funding Information:
The authors thank P.Dale and D.Stella for their technical assistance. We also thank Dr W.F.Morgan (University of California at San Francisco) for his assistance in designing the electroporation experiments; Drs E.Clark and C.E.Swenberg (Armed Forces Radwbiotogical Institute) for supplying WR-33278; Dr R.C.Fahey, G.L.Newton and J.A.Aguilera (University of California at San Diego) for measuring the intracellular content of WR-33278 following electroporation; Dr B.Carnes for his assistance in data analysis and statistics; and J.Lear for help in the preparation of this manuscript. This work was supported by the US Department of Energy, Office of Health and Environmental Research, under Contract W-31-1O9-ENG-38; by NIH/National Cancer Institute Grant CA-37435, and by the Center for Radiation Therapy (D.J.G.). J.L.S. was the recipient of an American Cancer Society Faculty Research Award.
PY - 1994/7
Y1 - 1994/7
N2 - The polyamine spermine and the disulfide N, N-(dithiodi-2, 1-ethanediyl)bis-1, 3-propanediamine (WR-33278) are structurally similar agents capable of binding to DNA. WR-33278 is the disulfide moiety of the clinically studied radioprotective agent S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721). Because of their reported structural and functional similarities, it was of interest to compare their effects on cell survival and mutation induction at the hypoxanthine-guanine phosphoribosyl transferase (hprt) locus in Chinese hamster AA8 cells. WR-33278 and spermine (at concentrations of 0.01 and 0.001 mM) were electroporated into cells. Electroporation, 300 V and 125 F, was performed either 30 min prior to or 3 h following exposure of cells to 750 cGy of ionizing radiation. Electroporation alone reduced cell survival to 75% but had no effect on hprt mutation frequency. The electroporation of either spermine or WR-33278 at concentrations greater than 0.01 mM was extremely toxic. The exposure of cells to both electroporation and irradiation gave rise to enhanced cell killing and mutation induction, with the sequence of irradiation followed 3 h later by electroporation being the more toxic protocol. Cell survival was only enhanced following electroporation of 0.01 mM of spermine and WR-33278 30 min prior to irradiation. Protection against radiation-induced hprt mutations was observed for both spermine and WR-33278 under all experimental conditions tested. Spermine at exposure concentrations of 0.01 and 0.001 mM administered 30 min before or 3 h after irradiation reduced mutation frequencies by factors of 2.2, 1.2, 1.9 and 2.2, respectively. WR-33278 at concentrations of 0.01 and 0.001 mM administered 30 min or 3 h after irradiation with 750 cGy lowered mutation frequencies by factors of 1.8, 1.3, 1.4 and 2.0, respectively. These data suggest that the properties of radioprotection and chemoprevention exhibited by the phosphorothioate (WR-2721) and associated aminothiol (WR-1065) and disulfide (WR-33278) metabolites may be mediated in part via endogenous sperminelike polyamine processes (i.e. chromatin stabilization). Such a mechanism would have important implications with respect to the design and development of new generation drugs for use in radioprotection and chemoprevention.
AB - The polyamine spermine and the disulfide N, N-(dithiodi-2, 1-ethanediyl)bis-1, 3-propanediamine (WR-33278) are structurally similar agents capable of binding to DNA. WR-33278 is the disulfide moiety of the clinically studied radioprotective agent S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721). Because of their reported structural and functional similarities, it was of interest to compare their effects on cell survival and mutation induction at the hypoxanthine-guanine phosphoribosyl transferase (hprt) locus in Chinese hamster AA8 cells. WR-33278 and spermine (at concentrations of 0.01 and 0.001 mM) were electroporated into cells. Electroporation, 300 V and 125 F, was performed either 30 min prior to or 3 h following exposure of cells to 750 cGy of ionizing radiation. Electroporation alone reduced cell survival to 75% but had no effect on hprt mutation frequency. The electroporation of either spermine or WR-33278 at concentrations greater than 0.01 mM was extremely toxic. The exposure of cells to both electroporation and irradiation gave rise to enhanced cell killing and mutation induction, with the sequence of irradiation followed 3 h later by electroporation being the more toxic protocol. Cell survival was only enhanced following electroporation of 0.01 mM of spermine and WR-33278 30 min prior to irradiation. Protection against radiation-induced hprt mutations was observed for both spermine and WR-33278 under all experimental conditions tested. Spermine at exposure concentrations of 0.01 and 0.001 mM administered 30 min before or 3 h after irradiation reduced mutation frequencies by factors of 2.2, 1.2, 1.9 and 2.2, respectively. WR-33278 at concentrations of 0.01 and 0.001 mM administered 30 min or 3 h after irradiation with 750 cGy lowered mutation frequencies by factors of 1.8, 1.3, 1.4 and 2.0, respectively. These data suggest that the properties of radioprotection and chemoprevention exhibited by the phosphorothioate (WR-2721) and associated aminothiol (WR-1065) and disulfide (WR-33278) metabolites may be mediated in part via endogenous sperminelike polyamine processes (i.e. chromatin stabilization). Such a mechanism would have important implications with respect to the design and development of new generation drugs for use in radioprotection and chemoprevention.
UR - http://www.scopus.com/inward/record.url?scp=0028275119&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028275119&partnerID=8YFLogxK
U2 - 10.1093/mutage/9.4.355
DO - 10.1093/mutage/9.4.355
M3 - Article
C2 - 7968578
AN - SCOPUS:0028275119
SN - 0267-8357
VL - 9
SP - 355
EP - 360
JO - Mutagenesis
JF - Mutagenesis
IS - 4
ER -